- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Marksans Pharma's UK subsidiary secured market authorization for its Cetirizine Dihydrochloride 1 mg/ml Oral Solution. This clears the path for product launch, signaling future revenue potential.